These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Physician knowledge, attitudes, and behavior related to reporting adverse drug events. Rogers AS, Israel E, Smith CR, Levine D, McBean AM, Valente C, Faich G. Arch Intern Med; 1988 Jul; 148(7):1596-600. PubMed ID: 3382304 [Abstract] [Full Text] [Related]
11. The practitioner's role in detection of adverse drug reactions. Soffer A. Arch Intern Med; 1985 Feb; 145(2):232-3. PubMed ID: 3838430 [No Abstract] [Full Text] [Related]
14. Evaluating drugs after their approval for clinical use. Ray WA, Griffin MR, Avorn J. N Engl J Med; 1993 Dec 30; 329(27):2029-32. PubMed ID: 8018139 [No Abstract] [Full Text] [Related]
15. A quantitative analysis of adverse events and "overwarning" in drug labeling. Duke J, Friedlin J, Ryan P. Arch Intern Med; 2011 May 23; 171(10):944-6. PubMed ID: 21606101 [No Abstract] [Full Text] [Related]